Dr. Katz is the co-founder and director of CanSORT. He is a Professor of Medicine and Health Management & Policy at the University of Michigan. He was a Robert Wood Johnson Faculty Scholar in the UM Department of Medicine, and received formal training in health services research as a Robert Wood Johnson Clinical Scholar at the University of Washington, where he earned his MPH. He received his MD degree from the University of California, San Francisco and completed residency in Internal Medicine at the University of California, Los Angeles. He has published widely on the behavioral and structural determinants of the utilization and cost of medical care services in the United States and Canada.
Dr. Katz has received a number of project and program grants from the National Institutes of Health (NIH) to lead research that addresses cancer treatment communication, decision-making, and quality of care. His current research agenda involves studies of the quality of care and outcomes of screening and treatments for breast and colorectal cancer. Dr. Katz is Principal Investigator of the CanSORT P01 “The Challenge of Individualizing Treatments for Patients with Breast Cancer” which was funded in 2012 with over $13M. He leads the P01 through Administrative Core activities. In 2012, Dr. Katz was recipient of the UM Medical School Dean’s Award for Excellence in Health Services Research. He has also received an NCI Established Investigator in Cancer Control, Behavioral and Population Sciences Research Award (2006-2012). Dr. Katz’s other leadership positions include co-directorship of the Health Behavior and Outcomes (HBO) Program, which is the socio-behavioral research program at the UM Rogel Cancer Center, and Steering Committee member for the American Society for Clinical Oncology’s annual meeting on quality of cancer care. He also has extensive experience as an NIH reviewer.